Walpole, MA, United States of America

Mark Benjamin Volkin

This inventor holds 1 USPTO granted patent. Top assignees: Bowling Green State University, Vuronyx Technologies LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Benjamin Volkin. Retrieved from https://idiyas.com/inventor/mark-benjamin-volkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Benjamin Volkin: Innovator in Drug Detection Technology

Introduction

Mark Benjamin Volkin is an accomplished inventor based in Walpole, MA (US). He is known for his significant contributions to drug detection technology, particularly in the field of opioid testing. His innovative approach has the potential to enhance safety and health measures in various settings.

Latest Patents

Mark Volkin holds a patent for "Drug detection using cobalt thiocyanate and Eosin Y." This patent describes materials and methods for testing unknown substances for the presence of opioids. His work in this area is crucial for addressing the ongoing opioid crisis and improving detection methods.

Career Highlights

Throughout his career, Mark has worked with notable institutions, including Bowling Green State University and Vuronyx Technologies LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug detection.

Collaborations

Mark has collaborated with professionals such as Jeremy Canfield and Jon Sprague. These partnerships have contributed to the advancement of his research and the successful development of his patented technology.

Conclusion

Mark Benjamin Volkin is a notable inventor whose work in drug detection technology is making a significant impact. His innovative patent and collaborations highlight his commitment to improving safety in the detection of opioids.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…